Silence Other Stockholder Equity vs Net Receivables Analysis

SLN Stock  USD 6.45  0.15  2.27%   
Silence Therapeutics financial indicator trend analysis is much more than just breaking down Silence Therapeutics PLC prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Silence Therapeutics PLC is a good investment. Please check the relationship between Silence Therapeutics Other Stockholder Equity and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Other Stockholder Equity vs Net Receivables

Other Stockholder Equity vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Silence Therapeutics PLC Other Stockholder Equity account and Net Receivables. At this time, the significance of the direction appears to have strong relationship.
The correlation between Silence Therapeutics' Other Stockholder Equity and Net Receivables is 0.6. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Silence Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Silence Therapeutics' Other Stockholder Equity and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Silence Therapeutics PLC are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Stockholder Equity i.e., Silence Therapeutics' Other Stockholder Equity and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.6
Relationship DirectionPositive 
Relationship StrengthSignificant

Other Stockholder Equity

Net Receivables

Most indicators from Silence Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Silence Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Silence Therapeutics' Selling General Administrative is very stable compared to the past year. As of the 13th of December 2024, Enterprise Value is likely to grow to about 475.5 M, though Tax Provision is likely to grow to (6.7 M).
 2021 2022 2023 2024 (projected)
Interest Expense8K47K34K32.3K
Depreciation And Amortization427K482K498K274.8K

Silence Therapeutics fundamental ratios Correlations

0.60.86-0.070.95-0.86-0.920.320.870.12-0.350.920.680.890.890.680.860.890.880.980.790.81-0.14-0.66-0.40.69
0.60.79-0.40.43-0.3-0.630.150.33-0.02-0.10.350.450.60.670.720.480.70.440.60.490.88-0.13-0.32-0.240.78
0.860.79-0.480.72-0.54-0.850.350.55-0.01-0.320.670.520.750.930.680.650.960.730.860.630.95-0.16-0.55-0.230.87
-0.07-0.4-0.480.05-0.160.21-0.10.150.250.180.090.170.03-0.51-0.260.16-0.51-0.25-0.110.06-0.390.080.07-0.35-0.29
0.950.430.720.05-0.92-0.880.30.930.04-0.310.950.580.90.810.640.870.80.90.950.70.67-0.25-0.7-0.430.54
-0.86-0.3-0.54-0.16-0.920.75-0.21-1.00.040.34-0.96-0.46-0.8-0.7-0.51-0.78-0.67-0.83-0.88-0.56-0.480.320.540.51-0.37
-0.92-0.63-0.850.21-0.880.75-0.4-0.77-0.040.12-0.83-0.63-0.93-0.89-0.81-0.92-0.89-0.91-0.91-0.78-0.780.230.790.37-0.57
0.320.150.35-0.10.3-0.21-0.40.20.00.460.390.360.490.3-0.020.440.310.220.330.320.12-0.140.02-0.510.17
0.870.330.550.150.93-1.0-0.770.2-0.04-0.330.960.470.810.710.540.80.680.850.890.580.5-0.32-0.57-0.490.37
0.12-0.02-0.010.250.040.04-0.040.0-0.04-0.14-0.070.72-0.07-0.01-0.010.1-0.010.02-0.060.61-0.010.9-0.050.31-0.02
-0.35-0.1-0.320.18-0.310.340.120.46-0.33-0.14-0.26-0.060.01-0.39-0.040.05-0.38-0.3-0.33-0.11-0.36-0.130.09-0.15-0.43
0.920.350.670.090.95-0.96-0.830.390.96-0.07-0.260.50.880.760.50.840.750.840.940.610.57-0.36-0.56-0.570.48
0.680.450.520.170.58-0.46-0.630.360.470.72-0.060.50.590.510.470.680.510.520.550.960.480.51-0.42-0.150.38
0.890.60.750.030.9-0.8-0.930.490.81-0.070.010.880.590.750.710.960.760.80.910.690.7-0.38-0.66-0.630.56
0.890.670.93-0.510.81-0.7-0.890.30.71-0.01-0.390.760.510.750.710.671.00.90.890.650.83-0.16-0.61-0.170.67
0.680.720.68-0.260.64-0.51-0.81-0.020.54-0.01-0.040.50.470.710.710.70.720.770.670.640.75-0.14-0.85-0.020.43
0.860.480.650.160.87-0.78-0.920.440.80.10.050.840.680.960.670.70.670.790.840.780.6-0.24-0.73-0.550.42
0.890.70.96-0.510.8-0.67-0.890.310.68-0.01-0.380.750.510.761.00.720.670.870.90.660.87-0.16-0.61-0.180.72
0.880.440.73-0.250.9-0.83-0.910.220.850.02-0.30.840.520.80.90.770.790.870.870.70.65-0.18-0.81-0.160.39
0.980.60.86-0.110.95-0.88-0.910.330.89-0.06-0.330.940.550.910.890.670.840.90.870.670.81-0.32-0.64-0.470.71
0.790.490.630.060.7-0.56-0.780.320.580.61-0.110.610.960.690.650.640.780.660.70.670.590.39-0.64-0.10.42
0.810.880.95-0.390.67-0.48-0.780.120.5-0.01-0.360.570.480.70.830.750.60.870.650.810.59-0.15-0.56-0.20.91
-0.14-0.13-0.160.08-0.250.320.23-0.14-0.320.9-0.13-0.360.51-0.38-0.16-0.14-0.24-0.16-0.18-0.320.39-0.150.120.59-0.16
-0.66-0.32-0.550.07-0.70.540.790.02-0.57-0.050.09-0.56-0.42-0.66-0.61-0.85-0.73-0.61-0.81-0.64-0.64-0.560.12-0.05-0.25
-0.4-0.24-0.23-0.35-0.430.510.37-0.51-0.490.31-0.15-0.57-0.15-0.63-0.17-0.02-0.55-0.18-0.16-0.47-0.1-0.20.59-0.05-0.31
0.690.780.87-0.290.54-0.37-0.570.170.37-0.02-0.430.480.380.560.670.430.420.720.390.710.420.91-0.16-0.25-0.31
Click cells to compare fundamentals

Silence Therapeutics Account Relationship Matchups

Silence Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets46.1M86.0M96.2M107.5M93.8M98.5M
Other Current Liab5.1M21.8M6.2M589K14.0M14.7M
Total Current Liabilities9.7M25.6M15.2M21.9M17.8M18.7M
Total Stockholder Equity20.9M9.1M8.5M22.1M17.1M20.8M
Property Plant And Equipment Net611K1.1M1.9M2.2M1.8M1.9M
Net Debt(13.2M)(27.1M)(73.4M)(54.4M)(53.8M)(51.1M)
Retained Earnings(152.0M)(184.2M)(223.0M)(263.3M)(304.6M)(289.4M)
Accounts Payable6.9M2.3M4.1M3.2M2.6M1.7M
Cash13.5M27.4M73.5M54.8M54.0M56.7M
Non Current Assets Total8.6M9.6M9.9M10.8M12.8M8.2M
Non Currrent Assets Other20.0M(9.6M)(9.9M)(10.8M)2.6M2.7M
Cash And Short Term Investments33.5M37.4M73.5M71.1M54.0M56.7M
Common Stock Total Equity3.5M3.6M3.9M4.2M4.8M5.0M
Common Stock Shares Outstanding25.0M27.3M29.7M32.2M37.1M38.9M
Liabilities And Stockholders Equity46.1M86.0M96.2M107.5M93.8M98.5M
Non Current Liabilities Total15.5M51.3M72.5M63.5M59.0M62.0M
Other Current Assets885K9.6M4.3M8.2M26.8M28.1M
Other Stockholder Equity171.9M153.7M184.3M226.7M251.4M264.0M
Total Liab25.2M76.9M87.7M85.4M76.8M80.6M
Property Plant And Equipment Gross611K1.1M5.5M5.5M5.6M5.8M
Total Current Assets37.5M76.4M86.3M96.7M81.0M85.1M
Common Stock3.9M4.2M4.5M5.4M5.9M6.2M
Accumulated Other Comprehensive Income169.0M189.1M23.8M24.3M64.3M57.1M
Net Receivables3.1M29.3M8.5M17.3M18.8M19.8M
Good Will7.7M8.1M7.6M8.0M7.8M7.8M
Intangible Assets34K17K24K320K284K313.7K
Short Term Investments319K5.0M20.0M10M0.016.3M
Net Tangible Assets13.2M917K910K13.7M12.4M16.7M
Property Plant Equipment611K1.1M1.9M2.2M2.5M1.5M
Net Invested Capital20.9M9.1M8.5M22.1M17.1M18.9M
Net Working Capital27.8M50.8M71.2M74.7M63.3M56.0M
Capital Stock3.9M4.2M4.5M5.4M5.9M5.0M

Pair Trading with Silence Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Silence Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Silence Stock

  0.9VALN Valneva SE ADRPairCorr
  0.89ERNA Eterna TherapeuticsPairCorr

Moving against Silence Stock

  0.84DYAI Dyadic InternationalPairCorr
  0.78ESPR Esperion TherapeuticsPairCorr
  0.77BMY Bristol Myers SquibbPairCorr
  0.57GILD Gilead Sciences Sell-off TrendPairCorr
  0.37DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Silence Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Silence Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Silence Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Silence Therapeutics PLC to buy it.
The correlation of Silence Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silence Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silence Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Silence Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Silence Therapeutics PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silence Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silence Therapeutics Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silence Therapeutics Plc Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.76)
Revenue Per Share
0.429
Quarterly Revenue Growth
(0.93)
Return On Assets
(0.22)
Return On Equity
(0.64)
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.